New Management Options for End-Stage Chronic Liver Disease and Acute Liver Failure: Potential for Pediatric Patients

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.8, Iss.1, 2006-01, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ropivacaine clearance is reduced in chronic end-stage liver disease

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Emerging drugs for complications of end-stage liver disease

By Dowman Joanna K Holt Andrew P Newsome Philip N Adams David H

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 159-174

Informa Healthcare

Access to resources Recommend Favorite

Suramin: potential in acute liver failure

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1361-1363

Informa Healthcare

Access to resources Recommend Favorite

Invasive Pulmonary Aspergillosis in Patients with Acute-on-chronic Liver Failure

By Wu Z Ling Z Shao F Sheng J Li L

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1958-1965

Field House Publishing

Access to resources Recommend Favorite

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

Current Drug Metabolism, Vol. 12, Iss. 1, 2011-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite